Funded Tech Companies

Syndax Pharmaceuticals

Syndax Pharmaceuticals is a biopharmaceutical tech venture, located in Waltham. Financial backing was provided by BioMed Ventures, Fidelity Management & Research Company and OrbiMed.

Company Overview

Contact Information

Company Background Information

Overview

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is a Waltham, MA-based, oncology-focused biotechnology company that is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/2/2016

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Briggs Morrison

        

Chief Financial Officer

Allan Shaw

        

Chief Technical Officer

Peter Ordentlich

        

President

Michael Metzger

        

VP - Operations

Jeannette Hasapidis

        

Company Investors

• BioMed Ventures
• Fidelity Management & Research Company
• OrbiMed
• Jennison Associates
• Tavistock Life Sciences
• Delos Capital
• Domain Associates (Dennis Podlesak)
• EcoR1 Capital Management
• Arrowpoint Partners
• MPM Capital (Kim Kamdar)
• Forward Ventures
• RusnanoMedInvest
• Cormorant Asset Management
• Domain Associates (Kim Kamdar)
• Domain Associates (Kim Puloma Kamdar)
• Pappas Ventures (Arthur Klausner)
• MPM Capital (Steven St. Peter)
• Avalon Ventures

Browse more funded tech companies:

Syncurity | Synder

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary